News

Setting Dementia Research Priorities – Drawing lines in the Sand

During its successful third annual events in Toronto last November, the CCNA held a panel session discussing setting dementia research priorities with over 200 attendees. Dr. Howard Feldman kicked-off the session by asking attendees to consider the practical and ethical implications of setting research priorities. “It’s not only that we set research priorities, but we…

Funding Opportunity from CIHR IIPH and ICRH – Operating Grant: Network Environments for Indigenous Health Research (NEIHR)

CIHR’s Institute of Indigenous Peoples’ Health has announced the launch of a request for applications (RFA) for the Network Environments for Indigenous Health Research (NEIHR) development grants. NEIHR is a new 15 year $89.4M initiative that aims to establish a solid foundation for Indigenous health research driven by and grounded in Indigenous communities in Canada. This…

Request for Applications: CZI Neurodegeneration Challenge Network

The Chan Zuckerberg Initiative invites applications to join the CZI Neurodegeneration Challenge Network, an interdisciplinary collaborative initiative to increase understanding of the fundamental biology of neurodegenerative disorders. The goal of the CZI Neurodegeneration Challenge Network is to bring together outstanding, innovative, forward-thinking scientists to work on the challenge of neurodegenerative disorders, with a focus on…

CAHS Panel for the Assessment of Evidence and Best Practices for the development of a Canadian Dementia Strategy

CAHS Panel for the Assessment of Evidence and Best Practices for the development of a Canadian Dementia Strategy.  This panel of 6 experts was assembled at the request of PHAC. Canada’s aging population and the increasing prevalence of Alzheimer’s disease and other dementias pose a significant challenge for Canadian families and their caregivers, and more…

Repeated Exposure to Music may Impact Alzheimer’s disease

The following is a guest post written by Drs. Corinne Fischer, Luis Fornazzari, Tom Schweizer, Michael Thaut, David Munoz, and Joseph Barfett Over half a million Canadians are living with Alzheimer’s disease (AD), and this number is expected to rise – exponentially – over the next 30 years. To date, drug trials have not been…

Study of Genetics in Lewy Body Dementia Sheds Light on Disease Mechanisms

This study is an important first step in understanding the genetic aspects of Dementia with Lewy Bodies and helps to clarify the contribution of genetics to the development of this disease and its relationship to other neurodegenerative diseases. Dementia with Lewy bodies (DLB), the second most common form of dementia among elderly people after Alzheimer’s…